January/February 2016

Editors' Page

Allen C. Ho, MD, and Robert L. Avery, MD

News

Q&A With Allergan President and CEO Brent Saunders

EyewireTV sits down with Allergan to discuss how the company's merger with Pfizer will affect the retina industry.

Steve Daily, Executive Editor, Eyewire

American Academy of Ophthalmology 2015 Annual Meeting

Medical Update

Fellows' Financial Fitness Forum: Part Two

More advice for fellows on disciplined self-finance.

Jayanth Sridhar, MD

Ocular Drug Delivery: Targeting the Posterior Segment

Many efforts are under way to improve drug delivery to the back of the eye.

Aron Shapiro

Updates for Retina Coding: 2016

Pointers for avoiding confusion and steering clear of problems.

Riva Lee Asbell

Is Your EHR System a Good Fit for Your Practice?

EHR systems are not one-size-fits-all. Here are some tips for selecting a system that is right for your retina practice.

Scott Heintzeman and Dan Montzka, MD

Retinal Redetachment After Silicone Oil Removal

Proper choice of vitreoretinal techniques and endotamponade can lead to a high rate of anatomic success.

Ogugua N. Okonkwo, MD, FRCS(Edin), FWACS

Why “Not 20/20” After an Excellent Phacoemulsification Surgery?

Hazy media preoperatively may obscure subtle clues to retinal conditions.

Jay Chhablani, MD, and Vivek Gupta, MBBS

Ocular Drug Delivery Systems

A rundown of methods for releasing drugs into the eye.

Randall V. Wong, MD

Micropulse Laser Treatment for Macular Edema Resulting From Radiation Retinopathy

Tissue-sparing laser provides positive results.

Margaret Wong, MD, and Robert L. Halpern, MD

Microscope-Integrated Optical Coherence Tomography

Single-center experience with the Zeiss Rescan 700 microscope-mounted OCT system.

Matthew B. Donovan, BS; Amir Mohsenin, MD, PhD; Thomas A. Albini, MD; Sonia H. Yoo, MD; Harry W. Flynn Jr, MD; Janet L. Davis, MD; William W. Culbertson, MD; and Audina M. Berrocal, MD

Reversing Retinal Ischemia

Using encapsulated cell technology, a novel device may some day be used to treat inadequate oxygenation associated with common diseases.

Logan Christensen, MD, and Jeffrey L. Olson, MD

Induction of Pharmacologic Vitreolysis With an Integrin Antagonist

Results of a phase 2 study suggest efficacy and safety plus additional antiangiogenic benefit.

Peter K. Kaiser, MD

New Developments in Surgical Devices and Instrumentation

The field of retina continues to stay innovative, offering promise for a future of better outcomes.

Paulo Ricardo Chaves de Oliveira, MD, and David Robert Chow, MD, FRCS

Managing Macular Holes

Common questions associated with this anomaly are addressed.

Roomasa Channa, MD, and Adrienne W. Scott, MD

Portable Vitrectomy Today

Taking stock of currently available vitrectomy systems that could be used in an office setting.

John D. Pitcher III, MD

Image-Assisted Vitreoretinal Surgery: The Emergence of Intraoperative OCT

Why this imaging technology deserves a place in the surgical setting.

Mehnaz Khan, MD, MS, and Justis P. Ehlers, MD

The Retina OR of the Future

As technology improves and progresses, surgical procedures will become automated, more efficient, and safer.

Theodore Leng, MD, MS

Are Combined Procedures the Wave of the Future?

The Case for Phacovirectomy By Timothy G. Murray, MD, MBA
A Japanese Perspective By Yusuke Oshima, MD, PhD

5Q With Geeta Lalwani, MD

Geeta Lalwani, MD, is a vitreoretinal surgeon at Rocky Mountain Retina Associates in Boulder, Colo.